Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Monotherapy: Timing and Risk Factors
Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.16-20680
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2017
Authors
Publisher
Association for Research in Vision and Ophthalmology (ARVO)